Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Murillas

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Anales De Medicina Interna (Madrid, Spain : 1984)|August 26, 1998
[Factors related to mortality of aged patients hospitalized with community-acquired pneumonia]A Ramos Martínez, J L Portero Navío, P Sanz Carabaña, et al.
AIDS Research and Treatment|June 12, 2015
Relationships between Serum Levels of Atazanavir and Renal Toxicity or LithiasisC I Marinescu, M Leyes, M A Ribas, et al.
HIV Medicine|December 10, 2013
Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapyG Sampériz, D Guerrero, M López, et al.
HIV Medicine|January 15, 2014
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavirE Martinez, A Gonzalez-Cordon, E Ferrer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2012
Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS CohortC Manzardo, A Esteve, N Ortega, et al.
The Journal of Infection|June 24, 2008
HIV-1 infected patients older than 50 years. PISCIS cohort studyG Navarro, M M Nogueras, F Segura, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|December 6, 2011
[Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document]J Rodríguez-Baño, J R Paño-Pardo, L Alvarez-Rocha, et al.
BMJ Open|March 13, 2015
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trialE Shaw, J M Miró, M Puig-Asensio, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 6, 2016
Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV StudyM Laguno, M A Von Wichmann, E Van den Eynde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2016
Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus CoinfectionDavid Nicolás, Anna Esteve, Anna Cuadros, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Anales De Medicina Interna (Madrid, Spain : 1984)|August 26, 1998
[Factors related to mortality of aged patients hospitalized with community-acquired pneumonia]A Ramos Martínez, J L Portero Navío, P Sanz Carabaña, et al.
AIDS Research and Treatment|June 12, 2015
Relationships between Serum Levels of Atazanavir and Renal Toxicity or LithiasisC I Marinescu, M Leyes, M A Ribas, et al.
HIV Medicine|December 10, 2013
Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapyG Sampériz, D Guerrero, M López, et al.
HIV Medicine|January 15, 2014
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavirE Martinez, A Gonzalez-Cordon, E Ferrer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2012
Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS CohortC Manzardo, A Esteve, N Ortega, et al.
The Journal of Infection|June 24, 2008
HIV-1 infected patients older than 50 years. PISCIS cohort studyG Navarro, M M Nogueras, F Segura, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|December 6, 2011
[Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document]J Rodríguez-Baño, J R Paño-Pardo, L Alvarez-Rocha, et al.
BMJ Open|March 13, 2015
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trialE Shaw, J M Miró, M Puig-Asensio, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 6, 2016
Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV StudyM Laguno, M A Von Wichmann, E Van den Eynde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2016
Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus CoinfectionDavid Nicolás, Anna Esteve, Anna Cuadros, et al.
Pageof 2